Huahai Pharmaceutical (600521.SH): Adenosylcobalamin capsules obtained drug registration certificate

Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for adenosylcobalamin capsules approved and issued by the State Drug Administration. Adenosylcobalamin capsules are suitable for megaloblastic anemia, malnourished anemia, anemia during pregnancy, polyneuritis, radiculitis, trigeminal neuralgia, sciatica, and nerve palsy; they can also be used for adjuvant treatment of nutritional diseases and leukopenia caused by radiation and drugs.